Not medical advice. I am a software engineer, not a physician. This page documents my own protocol and the research I read while building it. Talk to a qualified clinician before changing your supplementation, diet or any treatment. Lab reference ranges quoted here vary by laboratory and by individual.
Affiliate disclosure: the iHerb links on this page carry a referral code and pay me a commission if you buy. It does not change your price, and I do not link anything I do not use myself.
Ashwagandha (Withania somnifera) is one of the most extensively studied adaptogenic herbs in modern clinical research. Used for over 3,000 years in Ayurvedic medicine, it has earned its reputation as a premier stress-modulating botanical. Among the many extracts available, KSM-66 stands out as the most clinically validated form — a full-spectrum root extract standardized to at least 5% withanolides, produced through a unique water-based extraction process that preserves the natural balance of the plant's bioactive compounds.
What makes ashwagandha particularly valuable in a modern supplement protocol is its dual action: it simultaneously reduces cortisol (the primary stress hormone) while supporting testosterone production and physical performance. This bidirectional hormonal modulation is rare among natural compounds and has been demonstrated across multiple randomized controlled trials. The clinical data shows cortisol reductions of approximately 30% and testosterone increases of approximately 17% in stressed adults.
Ashwagandha's adaptogenic effects operate through several interconnected pathways:
Why KSM-66? KSM-66 is a root-only extract standardized to ≥5% withanolides using a water-based process. It is the most studied ashwagandha extract in clinical trials (24+ human studies). Root extracts have a better safety profile and more consistent adaptogenic effects compared to whole-plant or leaf extracts, which contain higher concentrations of withaferin A (cytotoxic).
| Parameter | Recommendation |
|---|---|
| Product | Protocol for Life Balance KSM-66 Ashwagandha Root Extract |
| Dose | 600 mg per day (1 capsule) |
| Timing | With lunch (fat-containing meal improves absorption) |
| Cycling | 8 weeks on, 2 weeks off |
| Onset | Stress/anxiety effects within 2 weeks; hormonal effects at 8 weeks |
Cycling rationale: Ashwagandha modulates thyroid hormones (may increase T4/T3 conversion). Cycling prevents overstimulation of thyroid function. Monitor TSH if using continuously. Contraindicated in hyperthyroidism.
| Study | Finding | PMID |
|---|---|---|
| Chandrasekhar et al., 2012 | 600 mg/day KSM-66 reduced serum cortisol by 27.9% and improved stress resistance scores (DASS, PSS) vs. placebo over 60 days in chronically stressed adults | 23439798 |
| Lopresti et al., 2019 | 240 mg/day ashwagandha extract for 8 weeks increased morning testosterone by 14.7%, DHEA-S by 18.1%, and reduced cortisol by 11.4% in overweight men aged 40-70 | 30854916 |
| Shenoy et al., 2012 | KSM-66 supplementation significantly improved VO2max, time to exhaustion, and cardiorespiratory endurance in healthy athletic adults over 12 weeks | 21170205 |
These tests allow you to objectively measure ashwagandha's impact on your hormonal profile and verify that thyroid function remains balanced during supplementation.
Protocol for Life Balance — KSM-66 Ashwagandha Root Extract, 600 mg, 90 Veg Capsules
Price: $19.86
Buy on iHerb →
A landmark 12-month safety study published in Phytotherapy Research (2025) followed 191 participants taking KSM-66 ashwagandha root extract daily. Only 9.4% reported mild adverse events, with no significant changes in hepatic, renal, or thyroid function. Notably, serum cortisol declined modestly, testosterone increased significantly, and quality-of-life scores improved, with 68.7% showing overall clinical improvement. This is the longest controlled safety trial of any ashwagandha extract to date, addressing previous concerns about cycling requirements. Additionally, new clinical trials registered in 2025–2026 are examining KSM-66's effects on cognitive function in aging adults and exercise recovery in athletes, expanding its evidence base beyond the current 50+ published studies.